- Home
- AVDX vs CNTA Comparison
AVDX vs CNTA Comparison
Compare AVDX & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVDX
- CNTA
- Stock Information
- Founded
- AVDX 2000
- CNTA 2020
- Country
- AVDX United States
- CNTA United Kingdom
- Employees
- AVDX N/A
- CNTA N/A
- Industry
- AVDX EDP Services
- CNTA Biotechnology: Pharmaceutical Preparations
- Sector
- AVDX Technology
- CNTA Health Care
- Exchange
- AVDX Nasdaq
- CNTA Nasdaq
- Market Cap
- AVDX 2.0B
- CNTA 1.9B
- IPO Year
- AVDX 2021
- CNTA 2021
- Fundamental
- Price
- AVDX $9.85
- CNTA $15.57
- Analyst Decision
- AVDX Hold
- CNTA Strong Buy
- Analyst Count
- AVDX 15
- CNTA 11
- Target Price
- AVDX $10.04
- CNTA $28.90
- AVG Volume (30 Days)
- AVDX 1.9M
- CNTA 893.7K
- Earning Date
- AVDX 07-30-2025
- CNTA 08-12-2025
- Dividend Yield
- AVDX N/A
- CNTA N/A
- EPS Growth
- AVDX N/A
- CNTA N/A
- EPS
- AVDX 0.01
- CNTA N/A
- Revenue
- AVDX $441,284,000.00
- CNTA $15,000,000.00
- Revenue This Year
- AVDX $5.63
- CNTA N/A
- Revenue Next Year
- AVDX $9.83
- CNTA N/A
- P/E Ratio
- AVDX $1,102.23
- CNTA N/A
- Revenue Growth
- AVDX 10.46
- CNTA 118.88
- 52 Week Low
- AVDX $6.61
- CNTA $9.10
- 52 Week High
- AVDX $12.93
- CNTA $19.09
- Technical
- Relative Strength Index (RSI)
- AVDX 68.08
- CNTA 62.53
- Support Level
- AVDX $9.83
- CNTA $13.22
- Resistance Level
- AVDX $9.88
- CNTA $16.15
- Average True Range (ATR)
- AVDX 0.02
- CNTA 0.69
- MACD
- AVDX -0.01
- CNTA 0.14
- Stochastic Oscillator
- AVDX 54.55
- CNTA 73.21
About AVDX AvidXchange Holdings Inc.
AvidXchange Holdings Inc is a provider of AP automation software and payment solutions for middle-market businesses and their suppliers. It generates the majority of its sales from Payment revenue followed by Software revenue and Services revenue. The company generates revenue in the United States.
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.